Biomarkers and surrogate endpoints

Br J Clin Pharmacol. 2005 May;59(5):491-4. doi: 10.1111/j.1365-2125.2005.02435.x.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers*
  • Costs and Cost Analysis
  • Humans

Substances

  • Biomarkers